NEUP · Neuphoria Therapeutics Inc. · Analyst Estimates
Market Cap
$20.16M
Shares
5.40M
Analyst Estimates
Compare analyst forecasts for Neuphoria Therapeutics Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1191070
CUSIP
64136E102
13F (30d)
16 filings
16 filers
Visit website
Investor relations